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Summary. We investigated the molecular size of 
circulating immunoreactive ACTH by gel chroma-
tography in patients with ACTH hypersecretion 
due to various disorders of the hypothalamic-pitui-
tary-adrenal axis. 4 patients with Addison's dis-
ease, 2 with Nelson's syndrome, 4 with Cushing's 
disease, 6 with the ectopic ACTH syndrome (2 
bronchial carcinoma, 1 medullary carcinoma, 1 
metastatic islett cell carcinoma, 1 benign bronchial 
carcinoid and 1 patient with occult ectopic Cush-
ing's syndrome) and 1 patient with hypersecretion 
of ACTH from a clinically nonfunctioning pitui-
tary adenoma were studied. Analysis of the molec-
ular size of immunoreactive ACTH was performed 
by gel chromatography on a Sephadex G-75 col-
umn (superfine, 100 x 1.5 cm) equilibrated with 
1 % formic acid. 2 ml fractions were collected and 
evaporated to dryness. The ACTH content of the 
recovered sampies was determined by RIA. In 
Addison's disease, Nelson's syndrome and Cush-
ing's disease the plasma showed a single peak of 
ACTH immunoreactivity at the expected position 
of 1-39 ACTH. In the ectopic ACTH syndrome 
the plasma of 4 patients revealed at chromatogra-
phy at least one other peak eluting between the 
void volume and 1-39 ACTH suggestive of a high 
molecular weight form of ACTH whereas plasma 
of 2 patients showed only a single ACTH peak 
at the position oflabeled 1-39 ACTH. The patient 
with a clinically non-functioning pituitary ad-
enoma revealed a gel filtration pattern similar to 
the patients with ectopic ACTH syndrom and se-
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Abbreviations: ACTH = adrenocorticotropin; MSH = melano-
cyte stimulating hormone; I =iodine; POMC=proopiomeiano-
cortin; RIA=radioimmunoassay 
cretion of high molecular weight ACTH. We con-
clude that secretion ofhigh molecular weight forms 
of ACTH is not a unique feature of the ectopic 
ACTH syndrome. It may therefore not serve as 
a marker of the ectopic Cushing's syndrome in the 
differential diagnosis of the ACTH dependent 
Cushing's syndrome. Vice versa, lack of high mo-
lecular weight ACTH does not exelude an ectopic 
source of ACTH secretion as cause of Cushing's 
syndrome. 
Key words: ACTH - Cushing's syndrome pro-
opiomelanocortin - Nelson's syndrome Add-
ison's disease 
It has been established that the pituitary peptides 
ACTH, ß-lipotropin and ß-endorphin originate 
from a common precursor, proopiomelanocortin 
(POMC) [7, 8]. Abnormalities in the processing 
ofPOMC have been reported in the ectopic ACTH 
syndrome resulting in the secretion of various high 
molecular weight forms of ACTH [11, 15]. Since 
differentiation of patients with ectopic Cushing's 
syndrome from pituitary dependent Cushing's syn-
drome (Cushing's disease) may be difficult in some 
cases it has been suggested that variations in the 
secretion pattern of ACTH may have diagnostic 
significance [5]. 
Therefore, we investigated the diagnostic value 
of gel chromatography of plasma ACTH in var-
ious disorders of the hypothalamic-pituitary-adre-
nal axis. 
Patieots aod Methods 
The plasma of 4 patients with Addison's disease, 
2 patients with Nelson's syndrome, 4 patients with 
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Table 1. Clinical characteristics of patients with ACTH-hypersecretion 
Pat. Age Sex Diagnosis Treatment Plasma-ACTH Concentration 
(years) (pgjml) 
1. 44 F Addison's disease steroid replacement therapy 1800 
2. 56 F Addison's disease steroid replacement therapy 880 
3. 22 F Addison's disease steroid replacement therapy 680 
4. 35 M Addison's disease steroid replacement therapy 249 
5. 52 M Cushing's disease (mic.) bilateral adrenalectomy 396 
6. 31 F Cushing's disease (mic.) 78 
7. 59 F Cushing's disease (mic.) bilateral adrenalectomy 800 
8. 44 F Cushing's disease (mac.) transsphenoidal neurosurgery 696 
9. 42 F Nelson's syndrome bilateral adrenalectomy, irradiation 12700 
10. 56 F Nelson's syndrome bilateral adrenalectomy, irradiation 5287 
11. 66 M bronchial carcinoma adrenostatic therapy 3100 
12. 60 M bronchial carcinoma adrenostatic therapy 1200 
13. 42 M met. islet carcinoma adrenostatic therapy 605 
14. 45 F met. medullary carcin. adrenostatic therapy 438 
15. 29 F bronchial carcinoid bilateral adrenalectomy 545 
16. 37 F occult ectopic C. sy. adrenostatic therapy 300 
17. 46 M 'silent' pituit. aden. transsphenoidal neurosurgery 380 
F=female; M=male; mic.=microadenoma; mac.=macroadenoma; C. sy.=Cushing's syndrome 
pituitary dependent Cushing's disease (3 micro-, 
1 macroadenoma), 6 patients with the ectopic 
ACTH-dependent Cushing's syndrome and j pa-
tient with a clinically silent corticotropic pituitary 
adenoma was studied. 
Clinical details of the patients are summerized 
in Table 1. All patients with Nelson's syndrome 
had increased skin pigmentation and a surgically 
proven corticotropic macroadenoma following bi-
lateral adrenalectomy for pituitary dependent 
Cushing's disease. In patients with Cushing's dis-
ease the pituitary source of ACTH hypersecretion 
was confirmed by neurosurgery or by se1ective 
catheterization of the sinus petrosus inferior [3]. 
Of the patients with the ectopic Cushing's syn-
drome 2 had small cell bronchial carcinoma, 1 had 
an islet cell carcinoma with diffuse metastases to 
the liver, 1 patient had metastatic medullary carci-
noma, 1 patient had a benign bronchial carcinoid 
and 1 patient suffered from the occult ectopic 
Cushing's syndrome [4]. The cases of the latter 
2 patients have been reported in detail e1sewhere 
[13]. The patient with a corticotropic macroaden-
oma confirmed by transsphenoidal neurosurgery 
showed elevated plasma Acnf levels without evi-
dence of Cushing's disease. His findings have been 
described previously [12] and were suggestive of 
a pituitary tumor secreting biologically inactive 
ACTH. 
Analysis of the molecular size of circulating im-
munoreactive ACTH was performed by gel chro-
matography, as described by Ratter et al. [11] in 
detail. Briefly, a column of Sephadex G-75 (super-
fine; 100 x 1.5 cm) equilibrated with 1 % formic 
acid was used. 2 ml preacidified plasma sampIes 
were applied to the coIumn and pumped down-
wards at a flow rate of 2,5 ml/hour. 2 ml sampies 
were collected and evaporated to dryness. The frac-
tions were reconstituted with a sodium phosphat 
buffer and set up for determination of immunore-
active ACTH. The ACTH content was measured 
in triplicate by radioimmunoassay [1]. The anti-
body cross-reacted complete1y with ACTH-(1-24), 
human(h) ACTH-(1--39), and ACTH-(11-24), and 
did not react with ACTH-(1-10), hACTH-(27-39), 
pbMSH, or iXhMSH. The minimal detectable con-
centration of immunoreactive ACTH was 5 pgjml. 
The colum was calibrated with dextran blue 
(void volume), I125-prolactin and I 125-ACTH_ 
(1-39). The recovery of nanogram amounts of 
1-39 ACTH added to acid-treated plasma contain-
ing no immunoreactive ACTH and applied to the 
column was over 75%. 
Results 
In patients with Addison's disease gel chromatog-
raphy revealed a single peak of immunoreactive 
ACTH eluting at the position of labeled 1-39 
ACTH. No other distinct peaks were seen in these 
patients. 
Patients with ACTH hypersecretion due to pi-
tuitary dependent Cushing's disease and Nelson's 
syndrome also demonstrated a single peak of im-
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Fig. 1. Gel filtration pattern of plasma ACTH obtained from 
2 patients with the ectopic ACTH syndrome due to a bronchial 
carcinoma 
munoreactive ACTH at the position of J125_1-39 
ACTH tracer representing ACTH with a molecular 
weight of 4500 daltons. No other significant peaks 
of ACTH immunoreactivity were detected. 
In patients with the ectopic ACTH syndrome 
gel chromatography of plasma sampies showed 
three different pattern. 
In patients with small cell carcinoma of the 
lung gel filtration revealed a small ACTH peak 
at the expected position of 1-39 ACTH together 
with several peaks of ACTH immunoreactivity 
eluting between the void volume and 1-39 ACTH, 
accounting for most of the ACTH detected 
(Fig. 1). These peaks were suggestive of multiple 
high molecular weight forms of ACTH indicating 
abnormal cleavage of the POMC precusor result-
ing in the release of peptides of different molecular 
weight by the tumor cells. 
In 2 patients with the ectopic ACTH syndrome 
(metastatic carcinoid and medullary carcinoma), 
in addition to a peak representing 1-39 ACTH, 
one other peak eluted midways between the void 
volume and 1-39 ACTH, eluting in the same posi-
tion as I125-prolactin (molecular weight 22000 dal-
tons) (Fig. 2). 
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Fig. 2. Gel filtration pattern of plasma ACTH from a patient 
with a metastatic islet cell carcinoma (above) and from a patient 
with a metastatic medullary carcinoma (bottom) 
In contrast, plasma sampies of the patient with 
occult ectopic Cushing's syndrome and of the pa-
tient with a benign bronchial carcinoid, respective-
ly, revealed a single peak of immunoreactive 
ACTH at the position of 1-39 ACTH without 
other distinct ACTH peaks. 
The plasma of the patient with a large aggres-
sive pituitary tumor and elevated plasma ACTH 
concentrations without signs of Cushing's disease 
showed a chromatographic profile of ACTH im-
munoreactivity similar to patients with ectopic 
ACTH syndrome: a very sm all peak appeared at 
the position of 1-39 ACTH; the second, predomi-
nant peak, eluting midway between the void vol-
urne and 1-39 ACTH, with a molecular weight of 
approximately 22000, indicated the presence of a 
large molecular weight form of ACTH, apparently 
without biological activity (Fig. 3). 
Discussion 
In the past decade it has been established that 
ACTH, ß-lipotropin and ß-endorphin originate 
from a common precursor known as proopiome-
lanocortin (pOMC) [8]. Production of ACTH and 
related peptides involves an intermediate step 
wherein the C-terminal ß-lipotropin is c1eaved first 
followed by the cleavage of ACTH [7]. Peptides 
derived from POMC are secreted concomitantly 
from the pituitary gland in response to diverse 
M. Reineke et al.: Gel Filtration Patterns in ACTH Hyperseeretion 
ACTH 60 
(pg/ml) 50 
40 
30 
20 
10 
60 
)125-
PROLACTIN 
t 
80 100 
1-39ACTH 
t 
120 
ELUTION VOLUME 
140 [mi] 
Fig. 3. Gel chromatographie eharaeterization ofplasma ACTH 
obtained from a patient with a eorticotropie pituitary adenoma 
and elevated plasma ACTH levels without evidence of Cush-
ing's syndrome 
stimuli. In normal subjects the only circulating 
form of ACTH immunoreactivity is 1-39 ACTH 
[11]. In patients with disorders of the hypothalam-
ic-pituitary-adrenal axis abnormalities of the pro-
cessing of POMC have been observed resulting in 
the secretion of various large molecular weight 
forms of ACTH [5, 6, 7,11,12,15,16]. In patients 
with Addison's disease, Nelson's syndrome and 
Cushing's disease we found only a single peak of 
immunoreactive ACTH eluting at the same posi-
tion as labeled 1-39 ACTH. These results are in 
accordance to the investigation of Ratter et al. [11]. 
In contrast, Thoren et al. [14] observed a high mo-
lecular weight form of ACTH in normal subjects 
and patients with Nelson's syndrome by gel filtra-
tion which eluted in the void volume. However, 
these findings may be explained by a non-specific 
binding ofthe antibody to non-ACTH related pep-
tides. 
High molecular weight forms of ACTH were 
first found in plasma of patients with the ectopic 
ACTH syndrome [15]. Consecutively, it has been 
suggested that variations in the secretion pattern 
of ACTH may have diagnostic significance in the 
ACTH dependent Cushing's syndrome [5]. Incom-
plete or aberrant processing of POMC with secre-
tion of'big' ACTH appeared to be a characteristic 
feature of the ectopic Cushing's syndrome. Ratter 
et al. [11] demonstrated at least one other peak 
of ACTH immunoreactivity suggestive of a high 
molecular weight form of ACTH in 20 patients 
with the ectopic ACTH syndrome. 
In some cases of the ectopic ACTH syndrome 
differentiation from pituitary dependent Cushing's 
disease may be difficult. Especially small or even 
occult ACTH secreting 'nonendocrine' tumors fre-
quently mimic biochemical characteristics of Cush-
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ing's disease [4]. Therefore, 'big' ACTH secretion 
by these tumors would be a useful marker of ec-
topic ACTH secretion and would facilitate the dif-
ferential diagnosis of ACTH dependent Cushing's 
syndrome. However, our results demonstrated that 
high molecular weight ACTH is not present in all 
cases of ectopic Cushing's syndrome. Seemingly se-
cretion of 'big' ACTH is a characteristic feature 
of malignant ACTH producing tumors (i.e. bron-
chial carcinomas) reflecting dedifferentiation of tu-
mor cells. In contrast, 'big' ACTH is lacking in 
plasma of our patients with the ectopic ACTH syn-
drome due to small benign or occult tumors. 
Therefore, lack of 'big' ACTH favours pituitary 
dependent Cushing's disease, but it does not ex-
elude ectopic ACTH secretion. 
Interestingly patients with Cushing's disease 
due to large aggressive pituitary tumors have been 
described with secretion of high molecular weight 
forms of ACTH [5, 6]. We observed a patient with 
hypersecretion of ACTH from an aggressive corti-
cotropic pituitary tumor who did not have hyper-
cortisolism. Gel chromatography of the patients 
plasma showed a pattern typical for the ectopic 
ACTH syndrome: 95% of the ACTH detected 
eluted midways between the void volume and 
1-39 ACTH. Since hypercortisolism was ruled out 
this high molecular weight form of ACTH had no 
or lütle bioactivity. These findings demonstrate 
that the secretion of 'big' ACTH is not a unique 
feature of the ectopic ACTH syndrome. It may 
also be present in rare ca ses of aggressive cortico-
tropic adenomas or carcinomas of the pituitary. 
It has been suggested that high molecular 
weight forms of ACTH are implicated in the mech-
anism underlying the appearance ofhypokaliaemia 
typical for patients with the ectopic Cushing's syn-
drome. In vitro there has been evidence of a poten-
tiation of the ACTH induced steroidogenesis by 
'big' ACTH in cuItered adrenocortical cells [10). 
However, Chatelain et al. [2] reported that 'big' 
ACTH did not modify the corticosteroidogenic ac-
tivity of 1-39 ACTH in perfused adrenal glands 
of the rat. Indirectly our results also are not in 
favour of this hypothesis since in our patients with 
ectopic ACTH syndrome without secretion of' big' 
ACTH (Pat. 15 and 16) hypokaliaemia or low nor-
mal potassium concentrations were observed. 
Therefore, hypokaliaemia in ectopic Cushing's 
syndrome may be more a result of greatly elevated 
plasma levels of 1-39 ACTH which in turn stimu-
late adrenal steroidogenesis. 
In conelusion, while the presence of high mo-
lecular weight ACTH favours the diagnosis of ec-
topic Cushing's syndrome, this is not a specific 
1100 
feature of it. On the other hand, the absence of 
'big' ACTH in plasma will not rule out Cushing's 
syndrome due to a benign or an occult ectopic 
ACTH source. 
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